Literature DB >> 3224692

A national register for long-term oxygen therapy in chronic hypoxia: preliminary results.

K Ström1, J Boe.   

Abstract

A national register of patients undergoing long-term oxygen therapy in Sweden was started in 1987. Of the population of 8.4 million, 560 patients (267 males) were registered as undergoing domiciliary oxygen treatment on January 1, 1987. These registered patients, aged between 2-86 yrs (mean age 65 yrs), constituted some 90% of all patients receiving domiciliary oxygen therapy because of chronic hypoxaemia on that date. The chronic respiratory diseases leading to hypoxaemia (more than one diagnosis could be registered for each patient) were: chronic obstructive pulmonary disease (COPD) (393), sequelae from pulmonary tuberculosis (92), thoracic deformity (97), interstitial fibrosis (44), benign pleural disease (22) and others (84). Concentrators were used by 253 patients and high-pressure compressed gas cylinders by 307. Arterial blood gas analyses were registered for 547 patients. The mean arterial oxygen tension (PaO2) when breathing air was 6.5 +/- 1.1 kPa and 9.0 +/- 1.4 kPa when breathing oxygen. The mean arterial carbon dioxide tension (PaCO2) without oxygen was 6.5 +/- 1.5 kPa and 6.8 +/- 1.5 kPa with oxygen. The register forms a data-base which can be used for the evaluation of different home oxygen systems, regional differences in the access to treatment and treatment performance and decisions relating to health care economics.

Entities:  

Mesh:

Year:  1988        PMID: 3224692

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Long-term oxygen therapy in patients with diagnoses other than COPD.

Authors:  C F Donner; A Braghiroli; F Ioli; S Zaccaria
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Assessment and follow up of patients prescribed long term oxygen treatment.

Authors:  L J Restrick; E A Paul; G M Braid; P Cullinan; J Moore-Gillon; J A Wedzicha
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

3.  Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study.

Authors:  Magnus P Ekström; Anna Bornefalk-Hermansson; Amy P Abernethy; David C Currow
Journal:  BMJ       Date:  2014-01-30

4.  Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study.

Authors:  Magnus Ekström; Torbjörn Gustafson; Kurt Boman; Kenneth Nilsson; Göran Tornling; Nicola Murgia; Kjell Torén
Journal:  BMJ Open       Date:  2014-01-09       Impact factor: 2.692

5.  The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden.

Authors:  Hanan A Tanash; Fredrik Huss; Magnus Ekström
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-13

6.  Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease.

Authors:  Zainab Ahmadi; Josefin Sundh; Anna Bornefalk-Hermansson; Magnus Ekström
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

7.  Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease.

Authors:  Magnus P Ekström; Claes Jogréus; Kerstin E Ström
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

8.  Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study.

Authors:  Zainab Ahmadi; Anna Bornefalk-Hermansson; Karl A Franklin; Bengt Midgren; Magnus P Ekström
Journal:  Respir Res       Date:  2014-03-13

9.  A nationwide structure for valid long-term oxygen therapy: 29-year prospective data in Sweden.

Authors:  Magnus Ekström; Zainab Ahmadi; Hillevi Larsson; Tove Nilsson; Josefin Wahlberg; Kerstin E Ström; Bengt Midgren
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.